Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,389,629 papers from all fields of science
Search
Sign In
Create Free Account
Acetazolamide
Known as:
2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide
, 5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide
, Acetazolamide [Chemical/Ingredient]
Expand
A sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. Acetazolamide is a non-competitive inhibitor of carbonic…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
40 relations
12 HR Acetazolamide 500 MG Extended Release Oral Capsule [Diamox]
Acetazolamide 125 MG
Acetazolamide:ACnc:Pt:Urine:Qn
Acetazolamide:PrThr:Pt:Ser/Plas:Ord
Expand
Narrower (11)
Acetazolamide 500 MG Injection
Acetazolamide sodium
Ak-Zol
Diacarb
Expand
Broader (5)
Anticonvulsants
Carbonic Anhydrase Inhibitors
Diuretics
Enzyme Inhibitors
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Spontaneous CSF leaks: A paradigm for definitive repair and management of intracranial hypertension
B. Woodworth
,
A. Prince
,
+5 authors
J. Palmer
Otolaryngology Head & Neck Surgery
2008
Corpus ID: 19727011
Review
2007
Review
2007
Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness.
D. Leaf
,
D. Goldfarb
Journal of applied physiology
2007
Corpus ID: 5873210
Acetazolamide, a potent carbonic anhydrase (CA) inhibitor, is the most commonly used and best-studied agent for the amelioration…
Expand
Highly Cited
2005
Highly Cited
2005
Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
D. Vullo
,
A. Innocenti
,
+4 authors
C. Supuran
Bioorganic & Medicinal Chemistry Letters
2005
Corpus ID: 25244584
Highly Cited
2004
Highly Cited
2004
Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX.
F. Abbate
,
A. Casini
,
T. Owa
,
A. Scozzafava
,
C. Supuran
Bioorganic & Medicinal Chemistry Letters
2004
Corpus ID: 29907117
Review
2004
Review
2004
Zonisamide: chemistry, mechanism of action, and pharmacokinetics
I. Leppik
Seizure
2004
Corpus ID: 13458791
Highly Cited
1997
Highly Cited
1997
Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold
H. White
,
S. Brown
,
J. Woodhead
,
G. Skeen
,
H. Wolf
Epilepsy Research
1997
Corpus ID: 43300936
Highly Cited
1995
Highly Cited
1995
Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease.
Marshall W. Webster
,
Michel S. Makaroun
,
David L. Steed
,
Holly A. Smith
,
David W. Johnson
,
H. Yonas
Journal of Vascular Surgery
1995
Corpus ID: 22684616
Highly Cited
1986
Highly Cited
1986
Evaluation of the cerebral vasodilatory capacity by the acetazolamide test before EC-IC bypass surgery in patients with occlusion of the internal carotid artery.
S. Vorstrup
,
B. Brun
,
N. Lassen
Stroke
1986
Corpus ID: 1287266
Cerebral blood flow (CBF) was measured by xenon-133 inhalation tomography in 18 patients with cerebrovascular disease before and…
Expand
Highly Cited
1974
Highly Cited
1974
Role of cations, anions and carbonic anhydrase in fluid transport across rabbit corneal endothelium
J. Fischbarg
,
J. J. Lim
Journal of Physiology
1974
Corpus ID: 23828013
1. A small electrical potential difference (541 ± 48 μV, aqueous side negative) across rabbit corneal endothelium has been…
Expand
Highly Cited
1966
Highly Cited
1966
Purification and properties of human erythrocyte carbonic anhydrases.
Dirck V. Myers
,
Jacob A. Verpoorte
,
J. Edsall
Journal of Biological Chemistry
1966
Corpus ID: 8505930
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE